"Drugs, Generic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
| Descriptor ID |
D016568
|
| MeSH Number(s) |
D26.360
|
| Concept/Terms |
Drugs, Generic- Drugs, Generic
- Drugs, Nonproprietary
- Nonproprietary Drugs
- Generic Drugs
|
Below are MeSH descriptors whose meaning is more general than "Drugs, Generic".
Below are MeSH descriptors whose meaning is more specific than "Drugs, Generic".
This graph shows the total number of publications written about "Drugs, Generic" by people in this website by year, and whether "Drugs, Generic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drugs, Generic" by people in Profiles.
-
Robust morphogenesis by chaotic dynamics. Sci Rep. 2023 05 09; 13(1):7482.
-
Physician and Nurse Practitioner Attitudes on Generic Prescribing of Oral Contraceptive Pills and Antidepressants. J Gen Intern Med. 2020 12; 35(12):3478-3484.
-
Decreasing utilization and increasing prices of brand-name oral contraceptive pills: Implications to societal costs and market competition. PLoS One. 2020; 15(6):e0234463.
-
Development and testing of a web module to IMPROVE generic prescribing of oral contraceptives among primary care physicians. J Clin Pharm Ther. 2019 Aug; 44(4):579-587.
-
Generic Substitution Rates of Oral Contraceptives and Associated Out-of-Pocket Cost Savings Between January 2010 and December 2014. JAMA Intern Med. 2018 04 01; 178(4):561-563.
-
Biosimilars in Oncology in the United States: A Review. JAMA Oncol. 2018 Feb 01; 4(2):241-247.
-
21st century pharmacovigilance: efforts, roles, and responsibilities. Lancet Oncol. 2016 Nov; 17(11):e486-e492.
-
Prescription Trends-Brand-name Drugs vs Generic. JAMA Intern Med. 2016 10 01; 176(10):1573-1574.
-
New Onset Hypertension Linked to Generic Cyclosporine Substitution in Post-Renal Transplant Patient. Am J Nephrol. 2016; 44(3):219-23.
-
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States. J Natl Cancer Inst. 2016 Jul; 108(7).